Action signal — 🔍 Research

Surfaced by the 2026-10-09 actions digest.

Action: 🔍 Research (LOW) RSI: 23.8

Why this is in actions

Enliven Therapeutics slipped just under its 200-day after a steep month: clinical-stage veto. News receipt dates to June 21 — stale, not pulled for this move

Trade Summary

Stub — 🔍 Research means more research needed before action.

Sources

• Actions digest: 2026-10-09-actions-daily-digest
• Original row: | **ELVN** | $40.98 | reclaim of the 200-day ($41.05) | 23.8 | **-28.67%** | 92.48% | -0.2% | 2026-10-09 | monster-scan (Secular) | 🔍 Research | Enliven Therapeutics slipped just under its 200-day af
• Price truth: summaries